AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 295: E420-E427, 2008. First published June 3, 2008; doi:10.1152/ajpendo.90329.2008
0193-1849/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/2/E420    most recent
90329.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Hyyti, O. M.
Right arrow Articles by Portman, M. A.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyyti, O. M.
Right arrow Articles by Portman, M. A.

Cardioselective dominant-negative thyroid hormone receptor ({Delta}337T) modulates myocardial metabolism and contractile efficiency

Outi M. Hyyti,1,2,3 Aaron K. Olson,1,3 Ming Ge,1,3 Xue-Han Ning,1,3 Norman E. Buroker,1,3 Youngran Chung,4 Thomas Jue,4 and Michael A. Portman1,3

1Division of Cardiology, Department of Pediatrics and 2Department of Radiology, University of Washington; 3Children's Hospital and Regional Medical Center, Seattle, Washington; and 4Department of Biological Chemistry, University of California, Davis, California

Submitted 2 April 2008 ; accepted in final form 27 May 2008

Dominant-negative thyroid hormone receptors (TRs) show elevated expression relative to ligand-binding TRs during cardiac hypertrophy. We tested the hypothesis that overexpression of a dominant-negative TR alters cardiac metabolism and contractile efficiency (CE). We used mice expressing the cardioselective dominant-negative TRβ1 mutation {Delta}337T. Isolated working {Delta}337T hearts and nontransgenic control (Con) hearts were perfused with 13C-labeled free fatty acids (FFA), acetoacetate (ACAC), lactate, and glucose at physiological concentrations for 30 min. 13C NMR spectroscopy and isotopomer analyses were used to determine substrate flux and fractional contributions (Fc) of acetyl-CoA to the citric acid cycle (CAC). {Delta}337T hearts exhibited rate depression but higher developed pressure and CE, defined as work per oxygen consumption (MVO2). Unlabeled substrate Fc from endogenous sources was higher in {Delta}337T, but ACAC Fc was lower. Fluxes through CAC, lactate, ACAC, and FFA were reduced in {Delta}337T. CE and Fc differences were reversed by pacing {Delta}337T to Con rates, accompanied by an increase in FFA Fc. {Delta}337T hearts lacked the ability to increase MVO2. Decreases in protein expression for glucose transporter-4 and hexokinase-2 and increases in pyruvate dehydrogenase kinase-2 and -4 suggest that these hearts are unable to increase carbohydrate oxidation in response to stress. These data show that {Delta}337T alters the metabolic phenotype in murine heart by reducing substrate flux for multiple pathways. Some of these changes are heart rate dependent, indicating that the substrate shift may represent an accommodation to altered contractile protein kinetics, which can be disrupted by pacing stress.

glucose metabolism; free fatty acids



Address for reprint requests and other correspondence: M. A. Portman, Children's Hospital and Regional Medical Center MSW 4841, 4800 Sand Point Way NE, Seattle, WA, 98105 (e-mail: michael.portman{at}seattlechildrens.org)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.